10x Genomics, Inc. (TXG)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 10:02AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 3.45B |
| Enterprise Value | 3.16B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.48 |
| Price/Book (mrq) | 4.66 |
| Enterprise Value/Revenue | 5.10 |
| Enterprise Value/EBITDA | -15.39 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.89 |
| 52-Week Change 3 | -46.10% |
| S&P500 52-Week Change 3 | 21.23% |
| 52 Week High 3 | 63.57 |
| 52 Week Low 3 | 26.75 |
| 50-Day Moving Average 3 | 40.37 |
| 200-Day Moving Average 3 | 45.63 |
Share Statistics
| Avg Vol (3 month) 3 | 1.39M |
| Avg Vol (10 day) 3 | 1.67M |
| Shares Outstanding 5 | 105.11M |
| Implied Shares Outstanding 6 | 119.17M |
| Float 8 | 103.27M |
| % Held by Insiders 1 | 2.38% |
| % Held by Institutions 1 | 94.55% |
| Shares Short (Mar 28, 2024) 4 | 8.52M |
| Short Ratio (Mar 28, 2024) 4 | 6.32 |
| Short % of Float (Mar 28, 2024) 4 | 10.16% |
| Short % of Shares Outstanding (Mar 28, 2024) 4 | 7.15% |
| Shares Short (prior month Feb 29, 2024) 4 | 6.89M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -41.23% |
| Operating Margin (ttm) | -15.76% |
Management Effectiveness
| Return on Assets (ttm) | -12.22% |
| Return on Equity (ttm) | -32.98% |
Income Statement
| Revenue (ttm) | 618.73M |
| Revenue Per Share (ttm) | 5.28 |
| Quarterly Revenue Growth (yoy) | 17.80% |
| Gross Profit (ttm) | N/A |
| EBITDA | -159.44M |
| Net Income Avi to Common (ttm) | -255.1M |
| Diluted EPS (ttm) | -2.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 388.7M |
| Total Cash Per Share (mrq) | 3.26 |
| Total Debt (mrq) | 95.37M |
| Total Debt/Equity (mrq) | 12.87% |
| Current Ratio (mrq) | 4.69 |
| Book Value Per Share (mrq) | 6.22 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -15.2M |
| Levered Free Cash Flow (ttm) | 30.63M |
© 2024 Yahoo. All rights reserved.